Nuclear Receptor Coactivators

Advances in Pharmacology

Volumn 47, Issue C, 1999, Pages 89-112

  Westin, Stefan ^a   Rosenfeld, Michael G ^a   Glass, Christopher K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956770875     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60110-6     Document Type: Article

References (66)

1. Anzick S.L., Dononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.-Y., Sauter G., Kallioniemi O.-P., Trent J.M., and Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277 5328 (1997) 965-968
2. Arias J., Alberts A.S., Brindle P., Claret F.X., Smeal T., Karin M., Feramisco J., and Montminy M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370 (1994) 226-229
3. Barettino D., Vivanco Ruiz M.M., and Stunnenberg H.G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13 (1994) 3039-3049
4. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
5. Beato M., Herrlich P., and Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 (1995) 851-857
6. Bourguet W., Ruff M., Chambon P., Gronemeyer H., and Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375 (1995) 377-382
7. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Öhman L., Greene G.L., Gustafsson J.-A., and Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 6652 (1997) 753-758
8. Cavailles V., Dauvois S., Danielian P.S., and Parker M.G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 91 (1994) 10009-10013
9. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoarc S., Kushner P.J., and Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14 (1995) 3741-3751
10. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., and Evans R.M. Role of CBP/p300 in nuclear receptor signalling. Nature 383 (1996) 99-103
11. Chen J.D., and Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 (1995) 454-457
12. Chen J.-Y., Clifford J., Zusi C., Starrett J., Tortolani D., Ostrowski J., Reczek P.R., Chambon P., and Gronemeyer H. Two distinct actions of retinoid-receptor ligands. Nature 382 (1996) 819-822
13. Chen H., Lin R.J., Schiitz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., and Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90 3 (1997) 569-580
14. Danielian P.S., White R., Lees J.A., and Parker M.G. Identification of a conserved region required for hormone-dependent transcriptional activation by steroid hormone receptors. EMBO J. 11 (1992) 1025-1033
15. Durand B., Saunders M., Gaudon C., Roy B., Losson R., and Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13 (1994) 5370-5382
16. Eggert M., Mows C.C., Tripier D., Arnold R., Michel J., Nickel J., Schmidt S., Beato M., and Renkawitz R. A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. J. Biol. Chem. 270 51 (1995) 30755-30759
17. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
18. Fondell J.D., Ge H., and Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93 (1996) 8329-8333
19. Forman B.M., Umesono K., Chen J., and Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81 (1995) 541-550
20. Fraser R.A., Heard D.J., Adam S., Lavigne A.C., Le Douarin B., Tora L., Losson R., Rochette-Egly C., and Chambon P. The putative cofactor TIFα is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors. J. Biol. Chem. 273 26 (1998) 16199-16204
21. Glass C.K. Some new twists in the regulation of gene expression by thyroid hormone and retinoic acid receptors. J. Endocrinol 150 (1996) 349-357
22. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., and Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458
23. Hanstein B., Eckner R., DiRenzo J., Halachmi S., Liu H., Searcy B., Kurokawa R., and Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93 (1996) 11540-11545
24. Heery D.M., Kalkhoven E., Hoare S., and Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387 6634 (1997) 733-736
25. Hong H., Kohli K., Trivedi A., Johnson D.L., and Stallcup M.R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 93 (1996) 4948-4952
26. Hörlein A., Näär A., Heinzel T., Torchia J., Gloss B., Kurokawa R., Kamei Y., Ryan A., Söderström M., Glass C.K., and Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor is mediated by a nuclear receptor co-repressor, N-CoR. Nature 377 (1995) 397-404
27. Huang Z.J., Edery I., and Rosbach M. PAS is a dimerization domain common to Drosophila period and several transcription factors. Nature 364 (1993) 259-262
28. Kalkhoven E., Valentine J.E., Heery D.M., and Parker M.G. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17 1 (1998) 232-243
29. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.-C., Heyman R., Rose D., Glass C., and Rosenfeld M. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403-414
30. Kawasaki H., Eckner R., Yao T.-P., Taira K., Chiu R., Livingston D.M., and Yokoyama K.K. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393 (1998) 284-289
31. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., and Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 (1992) 771-774
32. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., Mullen T.-M., Glass C.K., and Rosenfeld M.G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279 (1998) 703-707
33. Kraus W.L., and Kadonaga J.T. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes & Dev. 12 3 (1998) 331-342
34. Kurokawa R., DiRenzo J., Boehm M., Sugarman J., Gloss B., Rosenfeld M.G., Heyman R.A., and Glass C.K. Regulation of retinoid signaling by receptor polarity and allosteric control of ligand binding. Nature 371 (1994) 528-531
35. Kurokawa R., Söderström M., Hörlein A., Halachmi S., Brown M., Rosenfeld M.G., and Glass C.K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377 (1995) 451-454
36. Kurokawa R., Kalafus D., Ogliastro M.-H., Kioussi C., Xu L., Torchia J., Rosenfeld M.G., and Glass C.K. Differential use of CREB binding protein-coactivator complexes. Science 279 (1998) 700-703
37. Le Douarin B., Zechel C., Gamier J.-M., Lutz Y., Tora L., Pierrat B., Heery D., Gronemeyer H., Chambon P., and Losson R. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14 (1995) 2020-2033
38. Le Douarin B., Nielson A.L., Gamier J.-M., Ichinose H., Jeanmougin F., Losson R., and Chambon P. A possible involvement of TIF1α and TIF1β in the epigenetic control of transcription by nuclear receptors. EMBO J. 15 23 (1996) 6701-6715
39. Lee J.W., Ryan F., Swaffield J.C., Johnston S.A., and Moore D.D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374 (1995) 91-94
40. Li H., Gomes P.J., and Chen J.D. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. USA 94 (1997) 8479-8484
41. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schiitz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
42. Meyer M., Gronemeyer H., Turcotte B., Bocquel M., Tasset D., and Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57 (1989) 433-442
43. Nakajima T., Uchida C., Anderson S.F., Lee C.-G., Hurwitz J., Parvin J.D., and Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90 (1997) 1107-1112
44. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., and Milburn M.V. Ligand binding and coactivator assembly of the peroxisome proliferator-activated receptor γ. Nature (1998) in press.
45. Ogryzko V.V., Kotani T., Zhang X., Schiitz R.L., Howard T., Yang X.-J., Howard B.H., Qin J., and Nakatani Y. Histone-like TAFs within the PCAF histone acetylase complex. Cell 94 (1998) 35-44
46. Oñate S.A., Tsai S.Y., Tsai M.-J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357
47. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., and Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 (1998) 829-839
48. Rachez C., Suldan Z., Ward J., Chang C.-P.B., Burakov D., Erdjument-Bromage H., Tempst P., and Freedman L.P. A novel protein complex that interacts with the vitamin Dreceptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes & Dev. 12 (1998) 1787-1800
49. Renaud J.-P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., and Moras D. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378 (1995) 681-689
50. Schulman I.G., Shao G., and Heyman R.A. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPAR-γ) heterodimers: intermolecular synergy requires only the PPAR-γ hormone-dependent activation function. Mol. Cell. Biol. 18 (1998) 3483-3494
51. Smith C.L., Oñate S.A., Tsai M.-J., and O'Malley B.W. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. USA 93 (1996) 8884-8888
52. Takeshita A., Cardona G.R., Koibuchi N., Suen C.-S., and Chin W.W. TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272 44 (1997) 27629-27634
53. Tone Y., Collingwood T.N., Adams M., and Chatterjee V.K. Functional analysis of a transactivation domain in the thyroid hormone beta receptor. J. Biol. Chem. 269 (1994) 31157-31161
54. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., and Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387 (1997) 677-684
55. Voegel J.J., Heine M.J.S., Zechel C., Chambon P., and Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15 14 (1996) 3667-3675
56. Voegel J.J., Heine M.J., Tini M., Vivat V., Chambon P., and Gronemeyer H. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17 2 (1998) 507-519
57. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., and Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. Nature 378 (1995) 690-697
58. Westin S., Kurokawa R., Nolte R.T., Wisely G.B., Mclnerney E.M., Rose D.W., Milburn M.V., Rosenfeld M.G., and Glass C.K. Interactions governing nuclear receptor heterodimer-coactivator complexes. Nature (1998) in press.
59. Williams S.P., and Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature 393 (1998) 392-396
60. Xu J., Qiu Y., DeMayo F.J., Tsai S.Y., Tsai M.-J., and O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279 (1998) 1922-1925
61. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., and Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382 6589 (1996) 319-324
62. Yao T.-P., Ku G., Zhou N., Scully R., and Livingston D.M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93 (1996) 10626-10631
63. Yao T.-P., Oh S.P., Fuchs M., Zhou N.-D., Ch'ng L.-E., Newsome D., Bronson R.T., Li E., Livingston D.M., and Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93 (1998) 361-372
64. 70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93 (1996) 5517-5521
65. Yuan C.-X., Ito M., Fondell J.D., Fu Z.-Y., and Roeder R.G. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sci. USA 95 (1998) 7939-7944
66. Zhu Y., Qi C., Jain S., Rao M.S., and Reddy J.K. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 272 41 (1997) 25500-25506